Concepts (154)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Retinopathy of Prematurity | 9 | 2024 | 439 | 2.100 |
Why?
|
Retinal Perforations | 4 | 2024 | 138 | 1.770 |
Why?
|
Visual Acuity | 13 | 2024 | 2676 | 1.750 |
Why?
|
Coloboma | 2 | 2024 | 60 | 1.360 |
Why?
|
Retinal Detachment | 5 | 2024 | 429 | 1.340 |
Why?
|
Vitrectomy | 6 | 2024 | 391 | 1.160 |
Why?
|
Fluorescein Angiography | 8 | 2024 | 1062 | 1.120 |
Why?
|
Fovea Centralis | 2 | 2024 | 126 | 0.980 |
Why?
|
Pentosan Sulfuric Polyester | 1 | 2024 | 9 | 0.960 |
Why?
|
Posterior Eye Segment | 1 | 2024 | 18 | 0.950 |
Why?
|
Albinism, Oculocutaneous | 1 | 2024 | 19 | 0.930 |
Why?
|
Lenses, Intraocular | 2 | 2023 | 139 | 0.930 |
Why?
|
Tomography, Optical Coherence | 9 | 2024 | 2923 | 0.890 |
Why?
|
Nystagmus, Pathologic | 1 | 2024 | 104 | 0.860 |
Why?
|
Eye Injuries, Penetrating | 1 | 2024 | 122 | 0.800 |
Why?
|
Phacoemulsification | 1 | 2023 | 150 | 0.740 |
Why?
|
Retinal Diseases | 2 | 2024 | 705 | 0.700 |
Why?
|
Retinal Vessels | 3 | 2024 | 854 | 0.670 |
Why?
|
Regional Blood Flow | 1 | 2023 | 1498 | 0.660 |
Why?
|
Keratoconus | 1 | 2020 | 113 | 0.630 |
Why?
|
Eye Neoplasms | 1 | 2020 | 307 | 0.620 |
Why?
|
Dry Eye Syndromes | 1 | 2022 | 387 | 0.590 |
Why?
|
Intravitreal Injections | 5 | 2024 | 385 | 0.570 |
Why?
|
Retina | 5 | 2023 | 2655 | 0.570 |
Why?
|
Orbital Diseases | 1 | 2019 | 178 | 0.560 |
Why?
|
Cataract | 1 | 2023 | 828 | 0.550 |
Why?
|
Retinal Degeneration | 2 | 2024 | 414 | 0.490 |
Why?
|
Silicone Oils | 1 | 2024 | 22 | 0.470 |
Why?
|
Kearns-Sayre Syndrome | 1 | 2024 | 6 | 0.470 |
Why?
|
Endotamponade | 1 | 2024 | 37 | 0.470 |
Why?
|
Vitreous Hemorrhage | 1 | 2024 | 47 | 0.460 |
Why?
|
Photochemotherapy | 1 | 2020 | 826 | 0.460 |
Why?
|
Lens Subluxation | 1 | 2024 | 23 | 0.460 |
Why?
|
Histiocytic Necrotizing Lymphadenitis | 1 | 2024 | 27 | 0.450 |
Why?
|
Recovery of Function | 1 | 2024 | 2981 | 0.440 |
Why?
|
Retinal Vasculitis | 1 | 2024 | 46 | 0.440 |
Why?
|
Eye Diseases | 1 | 2019 | 653 | 0.440 |
Why?
|
Vitreous Detachment | 1 | 2023 | 22 | 0.440 |
Why?
|
Retinoschisis | 1 | 2023 | 30 | 0.430 |
Why?
|
Sickle Cell Trait | 1 | 2024 | 85 | 0.430 |
Why?
|
Hemangioblastoma | 1 | 2022 | 62 | 0.400 |
Why?
|
Lens, Crystalline | 1 | 2024 | 385 | 0.390 |
Why?
|
Endophthalmitis | 1 | 2024 | 260 | 0.380 |
Why?
|
Eye Infections, Bacterial | 1 | 2024 | 241 | 0.380 |
Why?
|
Choroid | 1 | 2024 | 363 | 0.380 |
Why?
|
Myasthenia Gravis | 1 | 2024 | 214 | 0.380 |
Why?
|
von Hippel-Lindau Disease | 1 | 2022 | 151 | 0.370 |
Why?
|
Turner Syndrome | 1 | 2022 | 129 | 0.370 |
Why?
|
Myopia | 1 | 2024 | 252 | 0.370 |
Why?
|
Retinal Neovascularization | 1 | 2024 | 288 | 0.360 |
Why?
|
Retinal Neoplasms | 1 | 2022 | 148 | 0.350 |
Why?
|
Choroidal Neovascularization | 1 | 2024 | 364 | 0.350 |
Why?
|
Cataract Extraction | 1 | 2024 | 463 | 0.350 |
Why?
|
Fundus Oculi | 3 | 2024 | 557 | 0.300 |
Why?
|
Fluorocarbons | 1 | 2023 | 492 | 0.300 |
Why?
|
Molecular Targeted Therapy | 1 | 2019 | 2813 | 0.290 |
Why?
|
Angiogenesis Inhibitors | 6 | 2024 | 2047 | 0.260 |
Why?
|
Gestational Age | 5 | 2024 | 3580 | 0.250 |
Why?
|
Retrospective Studies | 16 | 2024 | 80674 | 0.250 |
Why?
|
Nystagmus, Congenital | 1 | 2024 | 9 | 0.240 |
Why?
|
CHARGE Syndrome | 1 | 2024 | 34 | 0.240 |
Why?
|
Infant, Newborn | 10 | 2024 | 26199 | 0.230 |
Why?
|
Cystitis, Interstitial | 1 | 2024 | 66 | 0.230 |
Why?
|
Infant, Premature | 4 | 2024 | 2106 | 0.220 |
Why?
|
Scleral Buckling | 2 | 2024 | 95 | 0.220 |
Why?
|
Geographic Atrophy | 1 | 2024 | 91 | 0.210 |
Why?
|
Axial Length, Eye | 1 | 2023 | 35 | 0.210 |
Why?
|
Humans | 39 | 2024 | 761208 | 0.210 |
Why?
|
Eye Diseases, Hereditary | 1 | 2024 | 122 | 0.210 |
Why?
|
Aicardi Syndrome | 1 | 2023 | 16 | 0.210 |
Why?
|
Protein Kinase Inhibitors | 1 | 2019 | 5662 | 0.210 |
Why?
|
Meibomian Glands | 1 | 2022 | 73 | 0.210 |
Why?
|
Scleral Diseases | 1 | 2022 | 22 | 0.200 |
Why?
|
Melanoma | 1 | 2020 | 5694 | 0.200 |
Why?
|
Refraction, Ocular | 1 | 2023 | 184 | 0.190 |
Why?
|
Optics and Photonics | 1 | 2023 | 305 | 0.190 |
Why?
|
Skin Neoplasms | 1 | 2020 | 5809 | 0.180 |
Why?
|
Lens Implantation, Intraocular | 1 | 2022 | 190 | 0.180 |
Why?
|
Corneal Topography | 1 | 2020 | 68 | 0.180 |
Why?
|
Laser Coagulation | 1 | 2022 | 330 | 0.180 |
Why?
|
Riboflavin | 1 | 2020 | 107 | 0.170 |
Why?
|
Blindness | 1 | 2024 | 585 | 0.170 |
Why?
|
Vascular Endothelial Growth Factor A | 4 | 2024 | 3493 | 0.170 |
Why?
|
Biometry | 1 | 2023 | 563 | 0.170 |
Why?
|
Spasms, Infantile | 1 | 2023 | 298 | 0.160 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2023 | 3417 | 0.160 |
Why?
|
Atrophy | 2 | 2024 | 1633 | 0.150 |
Why?
|
Membrane Transport Proteins | 1 | 2024 | 1031 | 0.150 |
Why?
|
Cross-Linking Reagents | 1 | 2020 | 684 | 0.140 |
Why?
|
Heterozygote | 1 | 2024 | 2778 | 0.140 |
Why?
|
Infant | 6 | 2024 | 36169 | 0.140 |
Why?
|
Infant, Newborn, Diseases | 1 | 2022 | 589 | 0.140 |
Why?
|
Cysts | 1 | 2022 | 680 | 0.140 |
Why?
|
Photosensitizing Agents | 1 | 2020 | 625 | 0.130 |
Why?
|
Antineoplastic Agents | 1 | 2019 | 13632 | 0.130 |
Why?
|
Child | 8 | 2024 | 80152 | 0.130 |
Why?
|
Ultraviolet Rays | 1 | 2020 | 1078 | 0.130 |
Why?
|
Male | 16 | 2024 | 360693 | 0.120 |
Why?
|
Anemia, Sickle Cell | 1 | 2023 | 1063 | 0.120 |
Why?
|
Propionibacteriaceae | 1 | 2024 | 10 | 0.120 |
Why?
|
Female | 15 | 2024 | 392544 | 0.120 |
Why?
|
Anisocoria | 1 | 2024 | 9 | 0.120 |
Why?
|
Adolescent | 5 | 2024 | 88298 | 0.110 |
Why?
|
Diagnosis, Differential | 2 | 2024 | 12976 | 0.110 |
Why?
|
Retinal Artery Occlusion | 1 | 2024 | 77 | 0.110 |
Why?
|
Macula Lutea | 1 | 2024 | 177 | 0.110 |
Why?
|
Collagen | 1 | 2020 | 2635 | 0.100 |
Why?
|
Gram-Positive Bacterial Infections | 1 | 2024 | 342 | 0.100 |
Why?
|
Patient Positioning | 1 | 2024 | 326 | 0.100 |
Why?
|
Dissection | 1 | 2023 | 297 | 0.100 |
Why?
|
Artificial Intelligence | 2 | 2023 | 2576 | 0.090 |
Why?
|
Cost-Benefit Analysis | 1 | 2024 | 5493 | 0.090 |
Why?
|
Sclera | 2 | 2022 | 189 | 0.090 |
Why?
|
Follow-Up Studies | 2 | 2024 | 39126 | 0.090 |
Why?
|
Ophthalmologic Surgical Procedures | 1 | 2024 | 353 | 0.090 |
Why?
|
Birth Weight | 3 | 2023 | 2104 | 0.090 |
Why?
|
Capillaries | 1 | 2022 | 755 | 0.080 |
Why?
|
Ambulatory Surgical Procedures | 1 | 2024 | 463 | 0.080 |
Why?
|
DNA, Mitochondrial | 1 | 2024 | 865 | 0.080 |
Why?
|
X Chromosome | 1 | 2022 | 816 | 0.080 |
Why?
|
Young Adult | 2 | 2024 | 59221 | 0.070 |
Why?
|
Aged | 4 | 2024 | 169288 | 0.060 |
Why?
|
Child, Preschool | 2 | 2024 | 42224 | 0.060 |
Why?
|
Glucocorticoids | 1 | 2024 | 2159 | 0.060 |
Why?
|
Reoperation | 1 | 2024 | 4303 | 0.060 |
Why?
|
Adult | 5 | 2024 | 221119 | 0.060 |
Why?
|
Acute Disease | 1 | 2024 | 7226 | 0.060 |
Why?
|
Disease Management | 1 | 2024 | 2507 | 0.050 |
Why?
|
Treatment Outcome | 3 | 2024 | 64681 | 0.050 |
Why?
|
Middle Aged | 5 | 2024 | 220853 | 0.050 |
Why?
|
Vigabatrin | 1 | 2023 | 88 | 0.050 |
Why?
|
Recurrence | 1 | 2024 | 8457 | 0.050 |
Why?
|
Quality of Life | 1 | 2022 | 13367 | 0.050 |
Why?
|
Vascular Endothelial Growth Factors | 1 | 2022 | 748 | 0.050 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2019 | 5321 | 0.040 |
Why?
|
Infant, Very Low Birth Weight | 1 | 2023 | 407 | 0.040 |
Why?
|
Mutation | 1 | 2024 | 30002 | 0.040 |
Why?
|
Neonatal Screening | 1 | 2023 | 597 | 0.040 |
Why?
|
Infant, Low Birth Weight | 1 | 2022 | 869 | 0.040 |
Why?
|
Ophthalmology | 1 | 2024 | 550 | 0.040 |
Why?
|
Vision Disorders | 1 | 2023 | 1088 | 0.030 |
Why?
|
Anti-Bacterial Agents | 1 | 2024 | 7407 | 0.030 |
Why?
|
Lung Neoplasms | 1 | 2019 | 13385 | 0.030 |
Why?
|
Phenotype | 1 | 2022 | 16575 | 0.030 |
Why?
|
Academic Medical Centers | 1 | 2024 | 2756 | 0.030 |
Why?
|
Anticonvulsants | 1 | 2023 | 1910 | 0.030 |
Why?
|
Postoperative Complications | 1 | 2024 | 15637 | 0.020 |
Why?
|
Cohort Studies | 1 | 2024 | 41496 | 0.020 |
Why?
|
Risk Factors | 2 | 2023 | 74239 | 0.020 |
Why?
|
United States | 2 | 2024 | 72339 | 0.020 |
Why?
|
Antibodies, Monoclonal | 1 | 2022 | 9187 | 0.020 |
Why?
|
Incidence | 1 | 2023 | 21365 | 0.020 |
Why?
|
Algorithms | 1 | 2023 | 14025 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2022 | 58952 | 0.010 |
Why?
|
Concepts
(154)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(43)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_